SCHRODER INVESTMENT MANAGEMENT GROUP - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2021$294,000
-77.8%
6,150
-80.8%
0.00%
-100.0%
Q1 2021$1,324,000
-82.6%
32,059
-81.7%
0.00%
-60.0%
Q4 2020$7,594,000
+193.7%
175,050
+189.7%
0.01%
+25.0%
Q3 2020$2,586,00060,4280.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders